HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Sign In to gain access to subscriptions and/or personal tools.

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Request Reprints Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bogatov, V. B. Articles by Dahners, L. E. Search for Related Content PubMed PubMed Citation Articles by Bogatov, V. B. Articles by Dahners, L. E.

The Influence of a Cyclooxygenase-1 Inhibitor on Injured and Uninjured Ligaments in the Rat

Department of Orthopaedic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

^* Address correspondence and reprint requests to Laurence E. Dahners, MD, 237 Burnett-Womack Building, CB #7055, UNC School of Medicine, Chapel Hill, NC 27599-7055

Background: Results of previous studies have shown that piroxicam, a cyclooxygenase-1-2 inhibitor, improves the strength of healing ligaments, whereas celecoxib, a cyclooxygenase-2 inhibitor, impairs ligament healing.

Hypothesis: The selective cyclooxygenase-1 inhibitor, SC-560, will improve the strength of ligament healing in an in vivo rat model.

Study Design: Controlled laboratory study.

Methods: Eighty male Sprague-Dawley rats underwent surgical transection of their medial collateral ligament. Postoperatively, 20 rats were given SC-560 at a low dose and 20 at a high dose for the first 6 days of recovery; the other 40 received a normal diet. The animals were sacrificed 14 days later, and both the injured and uninjured ligaments were mechanically tested to failure in tension.

Results: No significant differences in the strength of injured ligaments were found between drug and placebo treatment. However, the contralateral uninjured ligaments in the SC-560-treated groups failed at 27% higher energy and 22% higher load.

Conclusions: This cyclooxygenase-1 inhibitor did not improve the strength of ligament healing but did significantly improve the strength of the contralateral uninjured ligament.

Clinical Relevance: A pure cyclooxygenase-1 inhibitor is probably not indicated as a positive influence on ligament healing but might provide benefits in ligament injury prevention.

This article has been cited by other articles:

				C. A. Hanson, P. S. Weinhold, H. M. Afshari, and L. E. Dahners The Effect of Analgesic Agents on the Healing Rat Medial Collateral Ligament Am. J. Sports Med., May 1, 2005; 33(5): 674 - 679. [Abstract] [Full Text] [PDF]

				O. Virchenko, B. Skoglund, and P. Aspenberg Parecoxib Impairs Early Tendon Repair but Improves Later Remodeling Am. J. Sports Med., October 1, 2004; 32(7): 1743 - 1747. [Abstract] [Full Text] [PDF]